Trial Profile
Phase IIb dose-ranging study of Linaclotide Colonic Release-2 (CR2) for Abdominal Pain in Non-Constipation Subtypes of IBS
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2021
Price :
$35
*
At a glance
- Drugs Linaclotide (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 08 May 2020 According to an Allergan media release, the AbbVie has completed the acquisition of Allergan.
- 28 Dec 2016 New trial record